ZL
Zealand Pharma A/S
ZLDPF · OTC
$43.00 +0.00% (+$0.00)
1M -10.86%
Market Cap 19.8B kr
P/E Ratio 7.26x
Div. Yield -
ROE 17.48%
Bulios Fair Price
$62.07
44.3% upside
Current Price
$43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ZLDPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
91 /100
Cheap EV/EBITDA 6.55x
P/S 4.28x
P/B 1.10x
Growth
100 /100
Growing Book val. growth 162.73%
Rev. growth 345.50%
FCF growth N/A
Profitability
70 /100
Strong Net margin 58.91%
Op. margin 50.46%
FCF margin 30.66%
Quality
69 /100
Excellent ROE 17.48%
ROA 13.84%
Asset turnover 0.23x
Debt
100 /100
Low Current ratio 13.98x
Int. coverage 60.76x
Net debt/EBITDA -1.46x
Stability
28 /100
Unstable Rev. volatility 8,368.17%
EPS volatility 376.65%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ZLDPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam Sinding Steensberg
Employees
481
Headquarters
Søborg
Upcoming events
12 NOV
Earnings
Upcoming earnings report